Journal Watch

Open

Advertisement

Journal Watch

1-20 of 2265 results
1 2 3 4 5 Next »

Transcatheter edge-to-edge repair for atrial secondary mitral regurgitation.

Nov 28, 2022 by
Michael Mahmoudi, MD - T Tanaka, et al.; JACC Cardiovasc Interv 2022; 15:1731-1740

Transcatheter edge-to-edge repair for atrial secondary mitral regurgitation.

Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.

Nov 28, 2022 by
Michael Mahmoudi, MD - Y Li, et al.; Lancet 2022 Online

Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.

Outcomes after transcatheter edge-to-edge mitral valve repair according to mitral regurgitation etiology and cardiac remodeling.

Nov 28, 2022 by
Michael Mahmoudi, MD - S Yoon et al.; JACC Cardiovasc Interv 2022; 15:1711-1722

Outcomes after transcatheter edge-to-edge mitral valve repair according to mitral regurgitation etiology and cardiac remodeling.

Small interfering RNA to reduce lipoprotein(a) in cardiovascular disease.

Nov 28, 2022 by
Michael Mahmoudi, MD - M O’Donoghue, et al.; NEJM 2022; 387:1855-1865

Small interfering RNA to reduce lipoprotein(a) in cardiovascular disease.

Prediction of death or HF hospitalization in patients with severe FMR: the COAPT risk score.

Oct 24, 2022 by
Michael Mahmoudi, MD - N Shah, et al.; JACC Intv 2022; 15:1893-1905

Prediction of death or HF hospitalization in patients with severe FMR: the COAPT risk score.

Canadian spontaneous coronary artery dissection cohort study: 3-year outcomes.

Oct 24, 2022 by
Michael Mahmoudi, MD - J Saw, et al.; JACC 2022; 80:1585-1597

Canadian spontaneous coronary artery dissection cohort study: 3-year outcomes.

Five-year outcomes of the Danish cardiovascular screening (DANCAVAS) trial.

Oct 24, 2022 by
Michael Mahmoudi, MD - J Lindholt, et al.; NEJM 2022; 387:1385-1394

Five-year outcomes of the Danish cardiovascular screening (DANCAVAS) trial.

Oxygen targets in comatose survivors of cardiac arrest.

Oct 24, 2022 by
Michael Mahmoudi, MD - H Schmidt et al.; NEJM 2022; 387:1467-1476

Oxygen targets in comatose survivors of cardiac arrest.

Percutaneous revascularization for ischemic ventricular dysfunction

Sep 26, 2022 by
Michael Mahmoudi, MD - D Perera, et al.; NEJM 2022 Online

Percutaneous revascularization for ischemic ventricular dysfunction

Polypill strategy in secondary cardiovascular prevention

Sep 26, 2022 by
Michael Mahmoudi, MD - J Castellano, et al.; NEJM 2022; 387:967-977

Polypill strategy in secondary cardiovascular prevention

Routine functional testing or standard care in high-risk patients after PCI

Sep 26, 2022 by
Michael Mahmoudi, MD - D Park, et al. NEJM 2022; 387:905-915

Routine functional testing or standard care in high-risk patients after PCI

Cerebral embolic protection during transcatheter aortic valve replacement

Sep 26, 2022 by
Michael Mahmoudi, MD - S Kapadia, et al.; NEJM 2022 Online

Cerebral embolic protection during transcatheter aortic valve replacement

Routine pressure wire assessment versus conventional angiography in the management of patients with coronary artery disease: The RIPCORD 2 trial

Aug 18, 2022 by
Michael Mahmoudi, MD - R Stables, et al.; Circ 2022 Online

Routine pressure wire assessment versus conventional angiography in the management of patients with coronary artery disease: The RIPCORD 2 trial

Cerebral microbleeds during transcatheter aortic valve replacement: a prospective magnetic resonance imaging cohort

Aug 18, 2022 by
Michael Mahmoudi, MD - E van Belle, et al.; Circ 2022; 146:383-397

Cerebral microbleeds during transcatheter aortic valve replacement: a prospective magnetic resonance imaging cohort

Study evaluating the use of RenalGuard to protect patients at high risk of AKI

Aug 18, 2022 by
Michael Mahmoudi, MD - S Mauler-Wittwer, et al.; JACC 2022; 15:1639-48

Study evaluating the use of RenalGuard to protect patients at high risk of AKI

Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction. The PACMAN-AMI randomized clinical trial.

Jul 31, 2022 by
Michael Mahmoudi, MD - L Raber, et al.; JAMA 2022; 327:1771-81

Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction. The PACMAN-AMI randomized clinical trial.

6-Month outcomes of the TricValve sytem in patients with tricuspid regurgitation: the TRICUS EURO study.

Jul 31, 2022 by
Michael Mahmoudi, MD - R Estevez-Loureiro, et al.; JACC Cardiol Interv 2022; 15:1366-77

6-Month outcomes of the TricValve sytem in patients with tricuspid regurgitation: the TRICUS EURO study.

Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis. A Randomized Clinical Trial.

Jul 31, 2022 by
Michael Mahmoudi, MD - The UK TAVI Trial Investigators.; JAMA 2022; 327:1875-1887

Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis. A Randomized Clinical Trial.

Sex differences in culprit plaque characteristics among different age groups in patients with acute coronary syndromes.

Jul 31, 2022 by
Michael Mahmoudi, MD - L Seegers, et al. ; Circ Cardiovasc Interv 2022; 15:e11612

Sex differences in culprit plaque characteristics among different age groups in patients with acute coronary syndromes.

Thin-cap fibroatheroma rather than any lipid plaques increases the risk of cardiovascular events in diabetic patients: insights from the COMBIN OCT-FFR trial.

Jun 27, 2022 by
Michael Mahmoudi, MD - E Fabris, et al.; Circ Cardiovasc Interv 2022; 15:e011728

Thin-cap fibroatheroma rather than any lipid plaques increases the risk of cardiovascular events in diabetic patients: insights from the COMBIN OCT-FFR trial.

1-20 of 2265 results
1 2 3 4 5 Next »

CRTonline on Facebook

CRTonline on Twitter

Tweets by CRT_meeting

Explore the Site

Stay Connected

CRT Group Foundation is a not for profit corporation dedicated to providing educational services in the field of cardiology through the website, CRTonline.org and the Cardiovascular Research Technologies (CRT) annual symposium. CRT focuses on the advances and changes in the field of cardiovascular medicine. CRT is designed to provide access to the world’s leading clinicians and the latest research in order to improve practice and treatment outcomes for a variety of health care professionals.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details

Refine Your Results

Search

Track

Type

Transcatheter edge-to-edge repair for atrial secondary mitral regurgitation.

Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial.

Outcomes after transcatheter edge-to-edge mitral valve repair according to mitral regurgitation etiology and cardiac remodeling.

Small interfering RNA to reduce lipoprotein(a) in cardiovascular disease.

Prediction of death or HF hospitalization in patients with severe FMR: the COAPT risk score.

Canadian spontaneous coronary artery dissection cohort study: 3-year outcomes.

Five-year outcomes of the Danish cardiovascular screening (DANCAVAS) trial.

Oxygen targets in comatose survivors of cardiac arrest.

Percutaneous revascularization for ischemic ventricular dysfunction

Polypill strategy in secondary cardiovascular prevention

Routine functional testing or standard care in high-risk patients after PCI

Cerebral embolic protection during transcatheter aortic valve replacement

Routine pressure wire assessment versus conventional angiography in the management of patients with coronary artery disease: The RIPCORD 2 trial

Cerebral microbleeds during transcatheter aortic valve replacement: a prospective magnetic resonance imaging cohort

Study evaluating the use of RenalGuard to protect patients at high risk of AKI

Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction. The PACMAN-AMI randomized clinical trial.

6-Month outcomes of the TricValve sytem in patients with tricuspid regurgitation: the TRICUS EURO study.

Effect of transcatheter aortic valve implantation vs surgical aortic valve replacement on all-cause mortality in patients with aortic stenosis. A Randomized Clinical Trial.

Sex differences in culprit plaque characteristics among different age groups in patients with acute coronary syndromes.

Thin-cap fibroatheroma rather than any lipid plaques increases the risk of cardiovascular events in diabetic patients: insights from the COMBIN OCT-FFR trial.

Explore the Site

Stay Connected

Journal Watch

Refine Your Results

Search

Track

Type

CRTonline on Facebook

CRTonline on Twitter

Explore the Site

Stay Connected